Hematopoietic Cancer Cells Potent Inhibitors of Proliferation of Prostate , Breast , and Analogs : A Unique Class of 319-nor-26 , 27-bishomo-Vitamin D Updated

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines.

  1998cited by this paper
• The 16-Ene Vitamin D Analogs

  1997cited by this paper
• 19-nor-hexafluoride analogue of vitamin D3: a novel class of potent inhibitors of proliferation of human breast cell lines.

  1997cited by this paper
• Vitamin D3 analogs and their 24‐Oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects

  1997cited by this paper
• Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin.

  1997cited by this paper
• Differentiation therapy of acute promyelocytic leukemia.

  1996cited by this paper
• A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia.

  1996cited by this paper
• Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels.

  1995cited by this paper
• and Inducers of Differentiation of Human Breast Cancer Cell Lines

  1995cited by this paper
• 1α,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol, a Noncalcemic Analogue of 1α,25-Dihydroxyvitamin D3, Inhibits Azoxymethane-induced Colonic Tumorigenesis

  1995cited by this paper
• Use of vitamins A and D in chemoprevention and therapy of cancer: control of nuclear receptor expression and function. Vitamins, cancer and receptors.

  1995cited by this paper
• Actions Of Vitamin D, Analogs on Human Prostate Cancer Cell Lines: Comparison with

  1995cited by this paper
• Vitamin D analogs: new therapeutic agents for the treatment of squamous cancer and its associated hypercalcemia

  1995cited by this paper
• Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells.

  1994cited by this paper
• Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.

  1994cited by this paper
• 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.

  1994cited by this paper
• Induction of glioma cell death by 1,25 (OH)2 vitamin D3: Towards an endocrine therapy of brain tumors?

  1994cited by this paper
• Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate.

  1994cited by this paper
• Effect of substituting fluorine for hydrogen at C-26 and C-27 on the side chain of 1,25-dihydroxyvitamin D3.

  1993cited by this paper
• Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro.

  1992cited by this paper
• A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia.

  1991cited by this paper
• Topical calcipotriol treatment in advanced breast cancer.

  1991cited by this paper
• Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism.

  1991cited by this paper
• All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results.

  1990cited by this paper
• 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice.

  1990cited by this paper
• Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization.

  1989cited by this paper
• The role of the vitamin D endocrine system in health and disease.

  1989cited by this paper
• Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.

  1984cited by this paper
• 1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells.

  1983cited by this paper
• Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites.

  1983cited by this paper
• Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.

  1981cited by this paper
• 1,25-dihydroxyvitamin-D-receptor in breast cancer cells.

  1979cited by this paper

• No citing papers are available for this paper.